[go: up one dir, main page]
Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1995 Jan;86(1):64–71. doi: 10.1111/j.1349-7006.1995.tb02989.x

Helicobacter pylori Infection, Serum Pepsinogen Level and Gastric Cancer: A Case‐Control Study in Japan

Haruhiko Fukuda 1, Daizo Saito 1, Shuya Hayashi 1, Hiroyuki Hisai 1, Hiroyuki Ono 1, Shigeaki Yoshida 1, Yanao Oguro 1, Takeshi Noda 1, Toshiya Sato 2, Masaru Katoh 3, Masaaki Terada 3, Takashi Sugimura 3
PMCID: PMC5920583  PMID: 7737912

Abstract

We conducted a case‐control study to evaluate the effect of Helicobacter pylori (HP) infection on the risk of gastric cancer in Tokyo, Japan. The sera at the time of diagnosis from 282 gastric cancer cases and 767 sex‐ and age‐matched cancer‐free controls were tested for the presence of anti‐HP IgG antibody (HM‐CAP ELISA kit) and serum pepsinogen (PG) level (PG I and PG II Riabead). No significant association was observed in all sets [matched odds ratio (OR)=1.04, 95% confidence interval: 0.73–1.49]. In subgroup analyses, however, an association was suggested in females [OR=1.57], a younger population (<50 years) [OR=1.86], early cancer [OR=1.53] and small cancer (<40 mm) [OR=1.55]. Furthermore, we observed a tendency for odds ratios to decrease with an increase in age or cancer growth (depth of tumor invasion and tumor size). Considering that the spontaneous disappearance of HP due to extended mucosal atrophy may lead to these decreasing odds ratios, we applied the conditional logistic model adjusted for the PG I/II ratio as a measure of atrophic gastritis. This analysis showed a positive association with HP infection in all sets [OR=1.69; 1.01–2.81], distal cancer [OR=1.88; 1.07–3.31] and intestinal‐type cancer [OR=3.76; 1.39–10.18]. We concluded that the risk of cancer associated with HP infection may be underestimated in studies with cross‐sectional exposure because of spontaneous disappearance of HP due to extended mucosal atrophy.

Keywords: Helicobacter pylori, Stomach neoplasm, Serum pepsinogen, Atrophic gastritis, Case‐control study

Full Text

The Full Text of this article is available as a PDF (446.1 KB).

REFERENCES

  • 1. ) Correa , P.Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention . Cancer Res. , 52 , 6735 – 6740 ( 1992. ). [PubMed] [Google Scholar]
  • 2. ) Parkin , M. D. , Stjernsward , J. and Muir , C.Estimates of the worldwide frequency of twelve major cancers . Int. J. Cancer , 41 , 184 – 197 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Palli , D. , Decarli , A. , Cipriani , F. , Forman , D. , Amadori , D. , Avellini , C. , Giacosa , A. , Manca , P. , Russo , A. , Salkeld , R. M. , Samloff , I. M. , Fraumoni , J. F. , Jr., Blot , W. J. and Buiatti , E.Plasma pepsinogens, nutrients, and diet in areas of Italy at varying gastric cancer risk . Cancer Epidemiol. Biomarkers Prev. , 1 , 45 – 50 ( 1991. ). [PubMed] [Google Scholar]
  • 4. ) Tsugane , S. , Kabuto , M. , Imai , H. , Gey , F. , Tei , Y. , Hanaoka , T. , Sugano , K. and Watanabe , S.Helicobacter pylori, dietary factors, and atrophic gastritis in five Japanese populations with different gastric cancer mortality . Cancer Causes Control , 4 , 297 – 305 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Correa , P. , Fox , J. , Fontham , E. , Ruiz , B. , Lin , Y. P. , Zavala , D. , Taylor , N. , Mackinley , D. , de Lima , E. , Portilla , H. and Zarama , G.Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks . Cancer , 66 , 2569 – 2574 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Forman , D. , Sitas , F. , Newell , D. G. , Stacey , A. R. , Boreham , J. , Peto , R. , Campbell , T. C. , Li , J. and Chen , J.Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China . Int. J. Cancer , 46 , 608 – 611 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Forman , D.Helicobacter pylori infection: a novel risk factor in the etiology of gastric cancer [editorial] . J. Natl. Cancer Inst. , 83 , 1702 – 1703 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Nomura , A. , Stemmermann , G. N. , Chyou , P. H. , Kato , I. , Perez , P. G. and Blaser , M. J.Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii . N. Engl. J. Med. , 325 , 1132 – 1136 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Parsonnet , J. , Friedman , G. D. , Vandersteen , D. P. , Chang , Y. , Vogelman , J. H. , Orentreich , N. and Sibley , R. K.Helicobacter pylori infection and the risk of gastric carcinoma . N. Engl. J. Med. , 325 , 1127 – 1131 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 10. ) Parsonnet , J. , Vandersteen , D. , Goates , J. , Sibley , R. K. , Pritikin , J. and Chang , Y.Helicobacter pylori infection in intestinal‐ and diffuse‐type gastric adenocarcinomas . J. Natl. Cancer Inst. , 83 , 640 – 643 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Talley , N. J. , Zinsmeister , A. R. , Weaver , A. , DiMagno , E. P. , Carpenter , H. A. , Perez , P. G. and Blaser , M. J.Gastric adenocarcinoma and Helicobacter pylori infection . J. Natl. Cancer Inst. , 83 , 1734 – 1739 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Sipponen , P. , Kosunen , T. U. , Valle , J. , Riihelar , M. and Seppala , K.Helicobacter pylori infection and chronic gastritis in gastric cancer . J. Clin. Pathol. , 45 , 319 – 323 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. ) Blaser , M. J. , Kobayashi , K. , Cover , T. L. , Cao , P. , Feurer , I. D. and Perez , P. G.Helicobacter pylori infection in Japanese patients with adenocarcinoma of the stomach . Int. J. Cancer , 55 , 799 – 802 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Evans , D. J. , Evans , D. G. , Graham , D. Y. and Klein , P. D.A sensitive and specific serologic test for detection of Campylobacter pylori infection . Gastroenterology , 96 , 1004 – 1008 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Breslow , N. E. and Day , N. E.“Statistical Methods in Cancer Research. Vol. 1 — The Analysis of Case‐Control Studies” ( 1980. ). Oxford University Press; , New York . [PubMed] [Google Scholar]
  • 16. ) Lauren , P.The two histological main types of gastric carcinoma: diffuse and so‐called intestinal‐type carcinoma . Acta Pathol. Microbiol. Scand. , 64 , 31 – 49 ( 1965. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Forman , D. , Newell , D. G. , Fullerton , F. , Yarnell , J. W. , Stacey , A. R. , Wald , N. and Sitas , F.Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation . Br. Med. J. , 302 , 1302 – 1305 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. ) Siurala , M. , Sipponen , P. and Kekki , M.Campylobacter pylori in a sample of Finnish population: relation to morphology and function of the gastric mucosa . Gut , 29 , 909 – 915 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. ) Asaka , M. , Kimura , T. , Kudo , M. , Takeda , H. , Mitani , S. , Miyazaki , T. , Miki , K. and Graham , D. Y.Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population . Gastroenterology , 102 , 760 – 766 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Karnes , W. J. , Samloff , I. M. , Siurala , M. , Kekki , M. , Sipponen , P. , Kim , S. W. and Walsh , J. H.Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis . Gastroenterology , 101 , 167 – 174 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Samloff , I. M. , Varis , K. , Ihamaki , T. , Siurala , M. and Rotter , J. I.Relationship among serum pepsinogen I, serum pepsinogen II and gastric mucosal histology: a study in relatives of patient with pernicious anemia . Gastroenterology , 83 , 204 – 209 ( 1982. ). [PubMed] [Google Scholar]
  • 22. ) Borch , K. , Axelsson , C. K. , Halgreen , H. , Damkjaer , N. M. , Ledin , T. and Szesci , P. B.The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis . Scand. J. Gastroenterol. , 24 , 870 – 876 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Kekki , M. , SamlofF , I. M. , Varis , K. and Ihamaki , T.Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis . Scand. J. Gastroenterol. Suppl. , 26 , 109 – 116 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 24. ) Sitas , F. , Smallwood , R. , Jewell , D. , Millard , P. R. , Newell , D. G. , Meuwissen , S. G. , Moses , S. , Zwiers , A. and Forman , D.Serum anti‐Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis . Cancer Epidemiol. Biomarkers Prev. , 2 , 119 – 123 ( 1993. ). [PubMed] [Google Scholar]
  • 25. ) Huang , S. C. , Miki , K. , Furihata , C. , Ichinose , M. , Shimizu , A. and Oka , H.Enzyme‐linked immunosorbent assays for serum pepsinogens I and II using monoclonal antibodies with data on peptic ulcer and gastric cancer . Clin. Chim. Acta , 175 , 37 – 50 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 26. ) Miki , K. , Ichinose , M. , Kawamura , N. , Matsushima , M. , Ahmad , H. B. , Kimura , M. , Sano , J. , Tashiro , T. , Kakei , N. , Oka , H. , Furihara , C. and Takahashi , K.The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects . Jpn. J. Cancer Res. , 80 , 111 – 114 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. ) Farinati , F. , Di , M. F. , Plebani , M. , Cielo , R. , Fanton , M. C. , Valiante , F. , Masiero , M. , De Boni , M. , Della , L. G. , Burlina , A. and Naccarato , R.Pepsinogen A/pepsinogen C or pepsinogen A multiplied by gastrin in the diagnosis of gastric cancer ? Ital. J. Gastroenterol. , 23 , 194 – 196 ( 1991. ). [PubMed] [Google Scholar]
  • 28. ) Varis , K. , Kekki , M. , Harkonen , M. , Sipponen , P. and Samloff , I. M.Serum pepsinogen I and serum gastrin in the screening of atrophic pangastritis with high risk of gastric cancer . Scand. J. Gastroenterol. Suppl. , 26 , 117 – 123 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 29. ) Matsukura , N. , Onda , M. , Tokunaga , A. , Fujita , I. , Okuda , T. , Mizutani , T. , Kyono , S. and Yamashita , K.Significance of serum markers pepsinogen I and II for chronic atrophic gastritis, peptic ulcer, and gastric cancer . J. Clin. Gastroenterol. Suppl. 1 , 17 , 146 – 150 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 30. ) Miki , K. , Ichinose , M. , Ishikawa , K. B. , Yahagi , N. , Matsushima , M. , Kakei , N. , Tsukada , S. , Kido , M. , Ishihama , S. , Shimizu , Y. , Suzuki , T. and Kurokawa , K.Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer . Jpn. J. Cancer Res. , 84 , 1086 – 1090 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. ) You , W. C. , Blot , W. J. , Zhang , L. , Kneller , R. W. , Li , J. Y. , Jin , M L. , Chang , Y. S. , Zeng , X. R. , Zhao , L. , Fraumeni , J. J. , Xu , G. and Samloff , I. M.Serum pepsinogens in relation to precancerous gastric lesions in a population at high risk for gastric cancer . Cancer Epidemiol. Biomarkers Prev. , 2 , 113 – 117 ( 1993. ). [PubMed] [Google Scholar]
  • 32. ) Parsonnet , J. , Samloff , I. M. , Nelson , L. M. , Orentreich , N. , Vogelman , J. H. and Friedman , G. D.Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma . Cancer Epidemiol. Biomarkers Prev. , 2 , 461 – 466 ( 1993. ). [PubMed] [Google Scholar]
  • 33. ) Sierra , R. , Munoz , N. , Pena , A. S. , Biemond , I. , van Duijn , W. , Lamers , C. B. , Teuchmann , S. , Hernandez , S. and Correa , P.Antibodies to Helicobacter pylori and pepsinogen levels in children from Costa Rica: comparison of two areas with different risks for stomach cancer . Cancer Epidemiol. Biomarkers Prev. , 1 , 449 – 454 ( 1992. ). [PubMed] [Google Scholar]
  • 34. ) Palli , D. , Decarli , A. , Cipriani , F. , Sitas , F. , Forman , D. , Amadori , D. , Avellini , C. , Giacosa , A. , Manca , P. , Russo , A. , Samloff , I. M. , Fraumeni , J. F. , Blot , W. J. and Buiatti , E.Helicobacter pylori antibodies in areas of Italy at varying gastric cancer risk . Cancer Epidemiol. Biomarkers Prev. , 2 , 37 – 40 ( 1993. ). [PubMed] [Google Scholar]
  • 35. ) Takahashi , S. , Igarashi , H. , Ishiyama , N. , Nakamura , K. , Masubuchi , N. , Ozaki , M. , Saito , S. , Aoyagi , T. , Itoh , T. and Hirata , I.Is Helicobacter pylori a causal agent in gastric carcinoma ? Int. J. Med. Microbiol. Virol. Parasitol. Infect. Dis. , 280 , 144 – 149 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 36. ) Fukao , A. , Komatsu , S. , Tsubono , Y. , Hisamichi , S. , Ohori , H. , Kizawa , T. , Ohsato , N. , Fujino , N. , Endo , N. and Iha , M.Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: a cross‐sectional study . Cancer Causes Control , 4 , 307 – 312 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 37. ) Estevens , J. , Fidalgo , P. , Tendeiro , T. , Chagas , C. , Ferra , A. , Leitao , C. N. and Mira , F. C.Anti‐Helicobacter pylori antibodies prevalence and gastric adenocarcinoma in Portugal: report of a case‐control study . Eur. J. Cancer Prev. , 2 , 377 – 380 ( 1993. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES